Atlas Trials

36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets

Clinical trial NCT02106442 · COMPLETED

Trial details

NCT number
NCT02106442
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Osteoporosis
Start date
2013-05-13
Primary completion
2018-04-30
Enrollment
579

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.